The University of Southern California (USC) has received a $6m grant from the California Institute for Regenerative Medicine ...

The treatment is expected to become the first gene therapy for glioblastoma utilising a precision delivery system to minimise harm to non-cancerous cells. Credit ...

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

However, complicated scenarios put forward new challenge for path planning of multiple UAVs. Therefore, a novel cylindrical coordinate particle swarm optimization (PSO) planner with gene targeting ...

The TP53 gene is a gene that is mutated in many cancers. It is the most common gene mutation found in cancer cells. A tumor-suppressor gene, TP53 codes for a protein that inhibits the development and ...

New gene editing methods have been introduced in the country, bringing new hope to couples who tested positive for certain ...

Forkhead box protein L2 (FOXL2) is a protein involved in ovary development and maintenance, among other functions. Mutations in its gene are involved in ovarian failure and granulosa cell tumors, ...

Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have discovered that about 5% of adult cancers rely heavily on a gene called PELO ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Stargardt disease type 1 (STGD1) is an inherited retinal recessive disease caused by biallelic variants in the ABCA4 gene. One of the recurrent variants is located at the exon-intron junction of exon ...

New research published in Developmental Cell provides evidence that targeting the KCNB2 gene could enhance current cancer treatments, tackling medulloblastoma tumour growth. “Tumour-propagating cells ...